Search results

Found 5,018 pages
AUTHOR: Selina McKee

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Rigel bags first FDA approval

Rigel Pharmaceuticals has bagged its first FDA approval, with a green light to market Tavalisse for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have failed to respond to previous treatment. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/rigel_bags_first_fda_approval_1232281

SmartPeople: Mark Samuels - PharmaTimes Magazine April 2018

The industry veteran talks about how he’s helping to change drug discovery as chief business and strategy officer of the new Medicines Discovery Catapult - Magazine Article - PharmaTimes

by Selina McKee

www.pharmatimes.com/magazine/2018/april_2018/smartpeople_mark_samuels

Shire turns down Takeda’s advances

Shire has now confirmed that it has thus far rejected three merger proposals from Takeda, the last one being valued at around $44 billion. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/shire_turns_down_takedas_advances_1232652

US expands use of Shire’s Vonvendi

US regulators have expended the scope of Shire’s Vonvendi to include perioperative management of bleeding in adults with von Willebrand disease (VWD). - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/us_expands_use_of_shires_vonvendi_1232279

Final NHS nod for Roche’s RoActemra

Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/final_nhs_nod_for_roches_roactemra_1232440

FDA clears first therapy for inherited rickets

US regulators have approved the first drug to treat adults and children with x-linked hypophosphatemia (XLH), a rare, inherited form of rickets. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/fda_clears_first_therapy_for_inherited_rickets_1232441

CR UK, AACR form international cancer alliance

Cancer Research UK and the American Association for Cancer Research (AACR) are launching a new international alliance dedicated to accelerating progress against cancer. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/cr_uk,_aacr_form_international_cancer_alliance_1232283

FDA advisors back approval of GW’s Epidiolex

As expected, an FDA advisory panel has backed approval of GW Pharmaceuticals/Greenwich Bioscience’s Epidiolex for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/fda_advisors_back_approval_of_gws_epidiolex_1232651

Merck sells consumer healthcare unit to P&G

Germany’s Merck is selling its consumer health unit to Procter & Gamble for around for 3.4 billion Euros. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/merck_sells_consumer_healthcare_unit_to_p_and_g_1232647

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download